Register for our free email digests:
Latest From Correlagen Diagnostics Inc.
With low-cost whole genome sequencing on the horizon, issues around acquiring and assessing large data sets of sequence information are front and center. The value proposition is also shifting, from the means of acquiring data to their interpretation. But finding a sustainable business model around data analysis and clinical services is far from straightforward.
- Medical Devices
- OTC, Consumer
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Xthetix Inc.
- Senior Management
- Brian D O'Connor, CEO
- Contact Info
Phone: (480) 649-4399
33 South Sycamore St.
Mesa, AZ 85202
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.